Home » Author Archive

Analysts Set Essent Group Ltd. (NYSE:ESNT) Price Target at $45.60

Posted by Matthew Jenks on Feb 7th, 2023

Shares of Essent Group Ltd. (NYSE:ESNT – Get Rating) have earned a consensus recommendation of “Hold” from the seven research firms that are currently covering the firm, MarketBeat Ratings reports. Three equities... More of this article »

Dynatrace’s (DT) Market Outperform Rating Reiterated at JMP Securities

Posted by Matthew Jenks on Feb 7th, 2023

JMP Securities reaffirmed their market outperform rating on shares of Dynatrace (NYSE:DT – Get Rating) in a research report sent to investors on Friday morning, Benzinga reports. They currently have a $50.00 price objective... More of this article »

Franklin Resources (NYSE:BEN) Cut to “Sell” at StockNews.com

Posted by Matthew Jenks on Feb 7th, 2023

StockNews.com lowered shares of Franklin Resources (NYSE:BEN – Get Rating) from a hold rating to a sell rating in a research note published on Friday. Other equities research analysts also recently issued research reports about... More of this article »

PENN Entertainment (NASDAQ:PENN) Stock Rating Upgraded by StockNews.com

Posted by Matthew Jenks on Feb 7th, 2023

StockNews.com upgraded shares of PENN Entertainment (NASDAQ:PENN – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Friday morning. Several other research firms have also issued reports... More of this article »

MoonLake Immunotherapeutics’ (MLTX) Buy Rating Reiterated at HC Wainwright

Posted by Matthew Jenks on Feb 7th, 2023

HC Wainwright reissued their buy rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Rating) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $28.00 price target... More of this article »